1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow Hyper-CVAD: new trials by email Literature Review of Hyper-CVAD trials Research Report on Hyper-CVAD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy Hyper-CVAD, Sirolimus - Lymphoid Malignancies (New or Relapsed), Acute Lymphoblastic Leukemia | Early Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 7 | 2010-07-01 | 2025-05-04 |
Burkitt Lymphoma (1) · Lymphoma, Mantle-Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (1)